Acute Myeloid Leukemia Measurable Residual Disease-12420

Test info

  
Acute Myeloid Leukemia Measurable Residual Disease
  
12420
  
LAB12420
  
PATR
  
AML MRD
Acute Leukemia
AML
Blast
Flow Cytometry
Residual AML
  
Tubes: M1, M2, M3, M4
Markers: CD2, CD5, CD7, CD10, CD11b, CD13, CD14, CD15, CD16, CD19, CD33, CD34, CD36, CD38, CD45, CD45RA, CD56, CD64, CD65, CD71, CD117, CD123, CD235a, CD300e, CD371, HLA-DR
  

Residual disease monitoring for patients with acute myeloid leukemia (AML)

  

Pathology orders only

Specimen

  
First-pull Sodium Heparin Bone Marrow Aspirate
  

Sodium heparinized (Na hep) syringe

  
3 mL
  
1 mL
  
  • Collect 3 mL (minimum 1 mL) in a sodium heparinized (Na hep) syringe; transfer to an anticoagulant free sterile tube
  • Specimens collected in EDTA are acceptable, but not preferred
  

Do not spin

  

Anticoagulant free sterile tube

  
Bone marrow core
  

RPMI with Hepes/Pen strep/FBS - 15 mL

 

  

Refrigerate

  

Original container.  Keep refrigerated.

  

Sodium Heparin or EDTA Bone Marrow

Ambient

 

RPMI Bone Marrow Core

Refrigerated

  
14 days
  
  • Improper label (unlabeled or mislabeled)
  • Wrong container (anticoagulant or solution)
    • Bone marrow cores submitted in saline or B+ fixative are not acceptable and will be rejected
  • Delay in transport
  • Improper storage
  • Interfering substances
  • Leaking container

Performance

  
AHL - Flow Cytometry: F
  
Mo - Fr
  
2 days
  

Flow cytometry

Clinical and Interpretive info

  

Tubes and Markers:

Tubes:

M1, M2, M3, M4

Markers:

CD2, CD5, CD7, CD10, CD11b, CD13, CD14, CD15, CD16, CD19, CD33, CD34, CD36, CD38, CD45, CD45RA, CD56, CD64, CD65, CD71, CD117, CD123, CD235a, CD300e, CD371, HLA-DR

Billing

  
88184
88185 x 25

Tracking

  
06/18/2024